Kexing Biopharm Revenue

In the year 2025, Kexing Biopharm had annual revenue of 1.54B CNY with 9.54% growth. Kexing Biopharm had revenue of 393.52M in the quarter ending December 31, 2025, with 6.74% growth.

Revenue

1.54B

Revenue Growth

+9.54%

P/S Ratio

3.84

Revenue / Employee

1.63M

Employees

971

Market Cap

5.92B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.54B	134.23M	9.54%
Dec 31, 2024	1.41B	147.89M	11.75%
Dec 31, 2023	1.26B	-56.84M	-4.32%
Dec 31, 2022	1.32B	30.70M	2.39%
Dec 31, 2021	1.29B	64.88M	5.32%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shouyao Holdings (Beijing) Co., LTD.	8.67M
Novogene	2.17B
Xiangxue Pharmaceutical	1.47B
R&G PharmaStudies	789.45M
GemPharmatech	793.25M
PharmaResources (Shanghai)	667.47M
Shanghai OPM Biosciences	354.91M
Beijing Konruns Pharmaceutical	871.31M

Revenue Rankings